CASE REPORT Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479 Preeti Chaudhary1, Mehmet Hepgur1, Sarmen Sarkissian2, Richard J.H. Smith3, Ilene C. Weitz1 1

Source URL: www.ncbi.nlm.nih.gov

• Biology
• Factor H
• Hemolytic-uremic syndrome
• Eculizumab
• Complement factor I
• Complement component 3
• Alternative complement pathway
• Alexion Pharmaceuticals
• CFHR1
• Complement system
• Anatomy
• Immune system